The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy

MLA

Han, Chongyang, et al. “The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy.” Molecular Pharmacology, vol. 94, no. 5, Jan. 2018, pp. 1256–69. EBSCOhost, https://doi.org/10.1124/mol.118.113076.

APA

Han, C., Themistocleous, A. C., Estacion, M., Dib-Hajj, F. B., Blesneac, I., Macala, L., Fratter, C., Bennett, D. L., Waxman, S. G., & Dib-Hajj, S. D. (2018). The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy. Molecular Pharmacology, 94(5), 1256–1269. https://doi.org/10.1124/mol.118.113076

Chicago

Han, Chongyang, Andreas C. Themistocleous, Mark Estacion, Fadia B. Dib-Hajj, Iulia Blesneac, Lawrence Macala, Carl Fratter, David L. Bennett, Stephen G. Waxman, and Sulayman D. Dib-Hajj. 2018. “The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy.” Molecular Pharmacology 94 (5): 1256–69. doi:10.1124/mol.118.113076.